Canada Carbon (CCB) Stock Chart & Stock Price History → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free CCB Stock Alerts C$0.06 -0.01 (-8.33%) (As of 09:50 AM ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Canada Carbon Stock Price Performance5 Day Performance0.00%1 Month Performance0.00%3 Month Performance+57.14%6 Month Performance+83.33%Year-To-Date Performance+57.14%1 Year Performance+22.22% Receive CCB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Canada Carbon and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... CCB Stock Chart for Friday, April, 26, 2024 CCB Chart by TradingView Canada Carbon Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024C$0.06C$0.06C$0.06C$0.055,100 shsC$10.69 million04/24/2024C$0.06C$0.06-8.33%C$0.06C$0.0635,000 shsC$10.69 million04/23/2024C$0.06C$0.06C$0.06C$0.0665,181 shsC$11.67 million04/22/2024C$0.06C$0.06+9.09%C$0.06C$0.0665,181 shsC$11.67 million04/19/2024C$0.06C$0.06C$0.06C$0.064,250 shsC$10.69 million04/18/2024C$0.05C$0.06+10.00%C$0.06C$0.0699,500 shsC$10.69 million Get the Latest News and Ratings for CCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Canada Carbon and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024C$0.06C$0.05-9.09%C$0.06C$0.05252,000 shsC$9.72 million04/16/2024C$0.06C$0.06C$0.06C$0.06280,000 shsC$10.69 million04/15/2024C$0.06C$0.06-8.33%C$0.06C$0.0690,000 shsC$10.69 million04/12/2024C$0.06C$0.06C$0.07C$0.06211,500 shsC$11.67 million04/11/2024C$0.06C$0.06C$0.07C$0.06179,527 shsC$11.67 million04/10/2024C$0.07C$0.06-7.69%C$0.06C$0.0616,500 shsC$11.67 million04/09/2024C$0.06C$0.07+8.33%C$0.07C$0.06147,500 shsC$12.64 million04/08/2024C$0.06C$0.06C$0.07C$0.06164,666 shsC$11.67 million04/05/2024C$0.06C$0.06C$0.07C$0.06223,300 shsC$11.67 million04/04/2024C$0.06C$0.06C$0.07C$0.06160,000 shsC$11.67 million04/03/2024C$0.06C$0.06C$0.07C$0.06192,333 shsC$11.67 million04/02/2024C$0.06C$0.06C$0.06C$0.0629,290 shsC$11.67 million04/01/2024C$0.06C$0.06+9.09%C$0.06C$0.0595,500 shsC$11.67 million03/29/2024C$0.06C$0.06C$0.06C$0.068,000 shsC$10.69 million03/28/2024C$0.06C$0.06C$0.06C$0.068,000 shsC$10.69 million03/27/2024C$0.06C$0.06C$0.06C$0.068,000 shsC$10.69 million03/26/2024C$0.06C$0.06C$0.06C$0.0519,000 shsC$10.69 million03/25/2024C$0.06C$0.06C$0.06C$0.0511,329 shsC$10.69 million03/22/2024C$0.05C$0.06+10.00%C$0.06C$0.0613,148 shsC$10.69 million03/21/2024C$0.06C$0.05-16.67%C$0.05C$0.0594,026 shsC$9.72 million03/20/2024C$0.07C$0.06-7.69%C$0.07C$0.05153,001 shsC$11.67 million03/19/2024C$0.07C$0.07C$0.07C$0.0672,379 shsC$12.64 million03/18/2024C$0.05C$0.07+30.00%C$0.07C$0.06363,995 shsC$12.64 million03/15/2024C$0.06C$0.05-16.67%C$0.06C$0.0550,150 shsC$9.72 million03/14/2024C$0.05C$0.06+20.00%C$0.06C$0.05162,218 shsC$11.67 million03/13/2024C$0.06C$0.05-9.09%C$0.06C$0.0572,000 shsC$9.72 million03/12/2024C$0.06C$0.06C$0.06C$0.0647,163 shsC$10.69 million03/11/2024C$0.06C$0.06C$0.06C$0.0579,165 shsC$10.69 million03/08/2024C$0.06C$0.06C$0.06C$0.0647,000 shsC$10.69 million03/07/2024C$0.06C$0.06C$0.06C$0.0688,125 shsC$10.69 million03/06/2024C$0.06C$0.06-8.33%C$0.06C$0.0655,800 shsC$10.69 million03/05/2024C$0.05C$0.06+20.00%C$0.07C$0.05124,800 shsC$11.67 million03/04/2024C$0.06C$0.05-16.67%C$0.06C$0.05140,892 shsC$9.72 million03/01/2024C$0.06C$0.06+9.09%C$0.06C$0.0673,000 shsC$11.67 millionJim Cramer’s “The Biggest Drug Ever” (Ad)This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here...02/29/2024C$0.06C$0.06-8.33%C$0.06C$0.06199,159 shsC$10.69 million02/28/2024C$0.05C$0.06+20.00%C$0.07C$0.06295,000 shsC$11.67 million02/27/2024C$0.06C$0.05-9.09%C$0.07C$0.051.41 million shsC$9.72 million02/26/2024C$0.06C$0.06C$0.06C$0.05179,050 shsC$10.69 million02/23/2024C$0.04C$0.06+37.50%C$0.06C$0.0585,011 shsC$10.69 million02/22/2024C$0.04C$0.04C$0.04C$0.04399,000 shsC$7.78 million02/21/2024C$0.04C$0.04C$0.04C$0.0417,000 shsC$7.78 million02/20/2024C$0.04C$0.04+14.29%C$0.04C$0.0453,621 shsC$7.78 million02/19/2024C$0.04C$0.04C$0.04C$0.0444,000 shsC$6.80 million02/16/2024C$0.03C$0.04+16.67%C$0.04C$0.0444,000 shsC$6.80 million02/15/2024C$0.04C$0.03-14.29%C$0.03C$0.0325,000 shsC$5.83 million02/14/2024C$0.04C$0.04C$0.04C$0.0440,092 shsC$6.80 million02/13/2024C$0.04C$0.04C$0.04C$0.0440,092 shsC$6.80 million02/12/2024C$0.04C$0.04C$0.04C$0.04271,117 shsC$6.80 million02/09/2024C$0.04C$0.04C$0.04C$0.0441,863 shsC$6.80 million02/08/2024C$0.04C$0.04C$0.04C$0.04161,000 shsC$6.80 million02/07/2024C$0.03C$0.04+16.67%C$0.04C$0.0427,000 shsC$6.80 million02/06/2024C$0.04C$0.03-14.29%C$0.03C$0.03210,000 shsC$5.83 million02/05/2024C$0.03C$0.04+16.67%C$0.04C$0.0358,167 shsC$6.80 million02/02/2024C$0.04C$0.03-14.29%C$0.03C$0.03322,367 shsC$5.83 million02/01/2024C$0.04C$0.04C$0.04C$0.03625,000 shsC$6.80 million01/31/2024C$0.04C$0.04C$0.04C$0.03625,000 shsC$6.80 million01/30/2024C$0.04C$0.04C$0.04C$0.0453,500 shsC$6.80 million01/29/2024C$0.04C$0.04C$0.04C$0.04299,000 shsC$6.80 million01/26/2024C$0.04C$0.04C$0.04C$0.04299,000 shsC$6.65 million01/25/2024C$0.04C$0.04C$0.04C$0.0415,000 shsC$6.65 million Related Companies: Focus Graphite Stock Price Chart Chatham Rock Phosphate Stock Price Chart TNR Gold Stock Price Chart New Age Metals Stock Price Chart Euromax Resources Stock Price Chart Imagine Lithium Stock Price Chart Scandium Canada Stock Price Chart Pacific Booker Minerals Stock Price Chart Black Mammoth Metals Stock Price Chart Deep-South Resources Stock Price Chart Receive CCB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Canada Carbon and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:CCB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canada Carbon Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
